Icotinib hydrochlorideProduct ingredient for Icotinib

Name
Icotinib hydrochloride
Drug Entry
Icotinib

Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Icotinib was approved in China by the SFDA in June, 2011 and in January 2014, Beta Pharma, Inc. was given a “May Proceed” from the US FDA to conduct a Phase I study for the evaluation of icotinib as a treatment of EGFR+ Non-Small Cell Lung Cancer (NSCLC).

Accession Number
DBSALT002060
Structure
Synonyms
Icotinib HCl
External IDs
BPI-2009H
UNII
JTD32I0J83
CAS Number
1204313-51-8
Weight
Average: 427.89
Monoisotopic: 427.1298839
Chemical Formula
C22H22ClN3O4
InChI Key
PNNGXMJMUUJHAV-UHFFFAOYSA-N
InChI
InChI=1S/C22H21N3O4.ClH/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20;/h1,3-5,12-15H,6-11H2,(H,23,24,25);1H
IUPAC Name
N-(3-ethynylphenyl)-7H,8H,10H,11H,13H,14H-1,4,7,10-tetraoxacyclododeca[2,3-g]quinazolin-4-amine hydrochloride
SMILES
Cl.C#CC1=CC=CC(NC2=NC=NC3=CC4=C(OCCOCCOCCO4)C=C23)=C1
ChemSpider
28637803
Predicted Properties
PropertyValueSource
Water Solubility0.0126 mg/mLALOGPS
logP2.88ALOGPS
logP3.03Chemaxon
logS-4.5ALOGPS
pKa (Strongest Acidic)16.14Chemaxon
pKa (Strongest Basic)4.62Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count7Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area74.73 Å2Chemaxon
Rotatable Bond Count2Chemaxon
Refractivity105.82 m3·mol-1Chemaxon
Polarizability42.03 Å3Chemaxon
Number of Rings4Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon